IMPERETUS LTD

Dissolved London

Management consultancy activities other than financial management

5 employees website.com
Life sciences and medical technology Management consultancy activities other than financial management
I

IMPERETUS LTD

Management consultancy activities other than financial management

Founded 9 Jun 2017 Dissolved London, England 5 employees website.com
Life sciences and medical technology Management consultancy activities other than financial management

Previous Company Names

RWE GENESYS LTD 9 Jun 2017 — 30 Apr 2021
Accounts Submitted 28 Sept 2023
Confirmation Submitted 29 Jun 2023 Next due 22 Jun 2024 23 months overdue
Net assets £0
Total assets £0
Total Liabilities £0
Charges None No charges registered

Contact & Details

Contact

Registered Address

10 Lower Thames Street London EC3R 6AF England

Telephone

0800 000 0000

Email

info@example.com

Website

www.example.com

Full company profile for IMPERETUS LTD (10811497), a dissolved life sciences and medical technology company based in London, England. Incorporated 9 Jun 2017. Management consultancy activities other than financial management. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2022
Type Total Exemption Full
Next accounts 31 December 2023
Due by 30 September 2024 9 months

Net Assets, Total Assets & Total Liabilities (2018–2022)

Cash in Bank

N/A

Net Assets

N/A

Total Liabilities

N/A

Turnover

N/A

Employees

5

Increased by 4 (+400%)

Debt Ratio

N/A

Financial History

Revenue, profit, EBITDA and key financial figures

2022
Dec Year End
2021
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Officers

Officers

2 active 1 resigned
Status
Gavin John CooperDirectorBritishEngland5723 Sept 2021Active
Thanjakumar Hermon ArulampalamDirectorBritishEngland5723 Sept 2021Active

Shareholders

Shareholders (1)

Colette Hamilton
100.0%
100

Persons with Significant Control

Persons with Significant Control (1)

1 Active 2 Ceased
Active
Notified 20 Feb 2024
Nature of Control
  • Significant Influence Or Control

Syeda Khatun Vazifdar

Ceased 26 Sept 2023

Ceased

Colette Hamilton

Ceased 26 Feb 2023

Ceased

Group Structure

Group Structure

IMPERETUS LTD Current Company

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
21 May 2024GazetteGazette Dissolved Voluntary
5 Mar 2024GazetteGazette Notice Voluntary
22 Feb 2024DissolutionDissolution Application Strike Off Company
21 Feb 2024Persons With Significant ControlEvidence for Access Limited notified as a person with significant control
21 Feb 2024OfficersAppointment of Evidence for Access as director on 20 Feb 2024
21 May 2024 Gazette

Gazette Dissolved Voluntary

5 Mar 2024 Gazette

Gazette Notice Voluntary

22 Feb 2024 Dissolution

Dissolution Application Strike Off Company

21 Feb 2024 Persons With Significant Control

Evidence for Access Limited notified as a person with significant control

21 Feb 2024 Officers

Appointment of Evidence for Access as director on 20 Feb 2024

Recent Activity

Latest Activity

Gazette Dissolved Voluntary

1 years ago on 21 May 2024

Gazette Notice Voluntary

2 years ago on 5 Mar 2024

Dissolution Application Strike Off Company

2 years ago on 22 Feb 2024

Evidence for Access Limited notified as a person with significant control

2 years ago on 21 Feb 2024

Appointment of Evidence for Access as director on 20 Feb 2024

2 years ago on 21 Feb 2024